MAP3K7 was also demonstrated to promote the degradation of AR protein levels in conjunction with a TNFa and NFKB-mediated inflammatory response, indicating that cancers with this Ch6q deletion may have elevated AR and reduced inflammation [142]. Here, AR is linked to cancer.